CART receptor binding in primary cell cultures of the rat nucleus accumbens

Synapse

Volumn 62, Issue 2, 2008, Pages 122-127

  Jones, Douglas C ^a   Kuhar, Michael J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

CART peptide; CART receptor; Nucleus accumbens

Indexed keywords

4 AMINOBUTYRIC ACID; COCAINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATE DERIVATIVE; IODINE 125; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; HYPOPHYSIS CELL; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANALYSIS OF VARIANCE; ANIMALS; BINDING, COMPETITIVE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; IODINE ISOTOPES; NERVE TISSUE PROTEINS; NEURONS; NUCLEUS ACCUMBENS; PROTEIN BINDING; RATS; RECEPTORS, CELL SURFACE;

EID: 37549031286     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20476     Document Type: Article

References (25)

1. Bannon AW, Seda J, Carmouche M, Francis JM, Jarosinski MA, Douglass J. 2001. Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J Pharmacol Exp Ther 299:1021-1026.
2. Dominguez G. 2006. The CART gene: Structure and regulation. Peptides 27:1913-1918 (Review).
3. Douglass J, McKinzie AA, Couceyro P. 1995. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481.
4. Hata I, Shigematsu Y, Ohshima Y, Tsukahara H, Fujisawa K, Hiraoka M, Nakamura H, Masutani H, Yodoi J, Kotsuji F, Sudo M, Mayumi M. 2001. Involvement of thioredoxin in the regulation of growth hormone secretion in rat pituitary cell cultures. Am J Physiol Endocrinol Metab 281:E269-E274.
5. Hoffman BB, Lefkowitz RJ. 1980. Radioligand binding studies of adrenergic receptors: New insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol 20:581-608.
6. Jaworski JN, Jones DC. 2006. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides 27:1993-2004 (Review).
7. Jaworski JN, Kozel MA, Philpot KB, Kuhar MJ. 2003. Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J Pharmacol Exp Ther 307:1038-1044.
8. Jaworski JN, Kimmel HL, Mitrano DA, Tallarida RJ, Kuhar MJ. 2007. Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: An isobolographic analysis. Neuropeptides 41:65-72.
9. Keller PA, Compan V, Bockaert J, Giacobino JP, Charnay Y, Bouras C, Assimacopoulos-Jeannet F. 2:006. Characterization and localization of cocaine- and amphetamine-regulated transcript (CART) binding sites. Peptides 27:1328-1334.
10. Kimmel HL, Gong W, Vechia SD, Hunter RG, Kuhar MJ. 2000. Intraventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J Pharmacol Exp Ther 294:784-792.
11. Kimmel HL, Thim L, Kuhar MJ. 2002. Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 36:9-12.
12. Koylu EO, Couceyro P, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ. 1997. Immuno-histochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 9:823-833.
13. Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ. 1998. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 391:115-132.
14. Kuhar MJ, Murrin LC, Malouf AT, Klemm N. 1978. Dopamine receptor binding in vivo: The feasibility of autoradiographic studies. Life Sci 22:203-210.
15. Lakatos A, Prinster S, Vicentic A, Hall RA, Kuhar MJ. 2005. Cocaine-and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci Lett 384:198-202.
16. Maletínská L, Maixnerová J, Matysková R, Haugvicová R, Sloncová E, Elbert T, Slaninová J, Zelezná B. 2007. Cocaine- and amphetamine-regulated transcript (CART) peptide specific binding in pheochromocytoma cells PC12. Eur J Pharmacol 559:109-114.
17. Sarkar S, Wittmann G, Fekete C, Lechan RM. 2004. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Res 999:181-192.
18. Spiess J, Villarreal J, Vale W. 1981. Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry 20:1982-1988.
19. Stein J, Shah R, Steiner DF, Dey A. 2006. RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor. Biochem J 400:209-215.
20. Vicentic A, Lakatos A, Kuhar MJ. 2005. CART (cocaine- and amphetamine-regulated transcript) peptide receptors: Specific binding in AtT20 cells. Eur J Pharmacol 528:188-189.
21. Vicentic A, Lakatos A, Jones DC. 2006. The CART receptors: Background and recent advances. Peptides 27:1934-1937.
22. Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P. 1999. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res 818:499-509.
23. Yang SC, Shieh KR, Li HY. 2005. Cocaine- and amphetamine-regulated transcript in the nucleus accumbens participates in the regulation of feeding behavior in rats. Neuroscience 133:841-851.
24. 2+ signaling in hippocampal neurons. J Neurosci 21:7474-80.
25. Zeevalk GD, Derr-Yellin E, Nicklas WJ. 1995. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther 275:1124-1130.